Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment
Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment
复制标题
DOI:
10.3928/23258160-20160229-04
复制
发表时间:
2016-03-01
影响因子:
1
通讯作者:
Sadda, SriniVas R.
中科院分区:
文献类型:
--
作者:
Kuehlewein, Laura;Dustin, Laurie;Sadda, SriniVas R.
BACKGROUND AND OBJECTIVE: To study the relationship between baseline morphologic characteristics of the choroidal neovascular (CNV) lesion and long-term development of macular atrophy in eyes with neovascular age-related macular degeneration (AMD) treated with ranibizumab (Lucentis; Genentech, South San Francisco, CA).PATIENTS AND METHODS: Certified graders evaluated baseline and 7-year follow-up (SEVEN-UP study) images of 41 eyes from the MARINA/ANCHOR and HORIZON trials. Using GRADOR software and stepwise linear regression, graders correlated lesion characteristics on fluorescein angiography (FA) at both visits with areas of definite decreased autofluorescence (DDAF) on fundus autofluorescence (FAF) imaging at the SEVEN-UP visit.RESULTS: Three of 41 eyes (7.3%) had macular atrophy on FA at baseline (mean +/- standard deviation [SD] size: 0.29 mm(2) +/- 1.50 mm(2)), 29 (70.7%) at SEVEN-UP (mean +/- standard deviation [SD] area: 7.42 mm(2) +/- 7.97 mm(2)). On FAF imaging at the SEVEN-UP visit, all 41 eyes (100%) had DDAF (mean +/- SD size: 10.29 mm(2) +/- 8.07 mm(2)). Variables significantly associated with area of DDAF at the SEVEN-UP visit were the area of leaking CNV lesion components (coefficient: 0.953; P